OncoMed EPS of -$8.83

|About: OncoMed Pharmaceuticals,... (OMED)|By:, SA News Editor

OncoMed (OMED): Q2 EPS of -$8.83 may not be comparable to consensus of  -$0.02.

Revenue of $2.9M may not be comparable to consensus of $8.31M. (PR)